Frederiksen H - Search Results

1

Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway.

Roaldsnes C, Holst R, Frederiksen H, Ghanima W. Roaldsnes C, et al. Among authors: frederiksen h. Eur J Haematol. 2017 Jan;98(1):85-93. doi: 10.1111/ejh.12788. Epub 2016 Sep 4. Eur J Haematol. 2017. PMID: 27500783

2

Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study.

Frederiksen H, Farkas DK, Christiansen CF, Hasselbalch HC, Sørensen HT. Frederiksen H, et al. Blood. 2011 Dec 15;118(25):6515-20. doi: 10.1182/blood-2011-04-348755. Epub 2011 Oct 28. Blood. 2011. PMID: 22039256 Free article.

3

Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET.

Cribe AS, Steenhof M, Marcher CW, Petersen H, Frederiksen H, Friis LS. Cribe AS, et al. Among authors: frederiksen h. Eur J Haematol. 2013 Apr;90(4):273-8. doi: 10.1111/ejh.12085. Eur J Haematol. 2013. PMID: 23470093

4

Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study.

Farmer S, Horváth-Puhó E, Vestergaard H, Hermann AP, Frederiksen H. Farmer S, et al. Among authors: frederiksen h. Br J Haematol. 2013 Dec;163(5):603-10. doi: 10.1111/bjh.12581. Epub 2013 Sep 30. Br J Haematol. 2013. PMID: 24111669 Free article.

5

Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study.

Frederiksen H, Maegbaek ML, Nørgaard M. Frederiksen H, et al. Br J Haematol. 2014 Jul;166(2):260-7. doi: 10.1111/bjh.12869. Epub 2014 Apr 2. Br J Haematol. 2014. PMID: 24690142 Free article.

6

Bone morbidity in chronic myeloproliferative neoplasms.

Farmer S, Ocias LF, Vestergaard H, Broesby-Olsen S, Hermann AP, Frederiksen H. Farmer S, et al. Among authors: frederiksen h. Expert Rev Hematol. 2015 Aug;8(4):447-56. doi: 10.1586/17474086.2015.1053456. Epub 2015 Jun 2. Expert Rev Hematol. 2015. PMID: 26036168 Review.

7

Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study.

Frederiksen H, Farkas DK, Christiansen CF, Larsen TS, Hasselbalch HC, Stentoft J, Sørensen HT. Frederiksen H, et al. Lancet Haematol. 2015 Jul;2(7):e289-96. doi: 10.1016/S2352-3026(15)00092-7. Epub 2015 Jun 11. Lancet Haematol. 2015. PMID: 26688384

8

Trends in hematological cancer in the elderly in Denmark, 1980-2012.

Ocias LF, Larsen TS, Vestergaard H, Friis LS, Abildgaard N, Frederiksen H; Academy of Geriatric Cancer Research (AgeCare). Ocias LF, et al. Among authors: frederiksen h. Acta Oncol. 2016;55 Suppl 1:98-107. doi: 10.3109/0284186X.2015.1115124. Epub 2016 Jan 19. Acta Oncol. 2016. PMID: 26783877

9

Response of first line treatment with corticosteroids in a population-based cohort of adults with primary immune thrombocytopenia.

Frederiksen H, Ghanima W. Frederiksen H, et al. Eur J Intern Med. 2017 Jan;37:e23-e25. doi: 10.1016/j.ejim.2016.09.001. Epub 2016 Sep 12. Eur J Intern Med. 2017. PMID: 27633568 No abstract available.

10

A systematic review of health-related quality of life in longitudinal studies of myeloma patients.

Nielsen LK, Jarden M, Andersen CL, Frederiksen H, Abildgaard N. Nielsen LK, et al. Among authors: frederiksen h. Eur J Haematol. 2017 Jul;99(1):3-17. doi: 10.1111/ejh.12882. Epub 2017 Apr 25. Eur J Haematol. 2017. PMID: 28322018 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

448 results

Search Page